Skip to main content
. 2020 Jan 2;35(1):25–40. doi: 10.3904/kjim.2019.388

Figure 2.

Figure 2.

Treatment approach for post-transplant thrombotic microangiopathy. Modified from Campistol et al. [36]. TMA, thrombotic microangiopathy; ADAMTS13, metalloproteinase with thrombospondin type 1 motif, member 13; STEC, Shiga toxin-producing Escherichia coli; DIC, disseminated intravascular coagulation; AMR, antibody mediated rejection; CMV, cytomegalovirus; PE, plasma exchange.